Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancer
Open Access
- 1 October 1990
- Vol. 66 (7), 1513-1516
- https://doi.org/10.1002/1097-0142(19901001)66:7<1513::aid-cncr2820660713>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Pathologic findings associated with interleukin-2—Based immunotherapy for cancer: A postmortem study of 19 patientsHuman Pathology, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.Proceedings of the National Academy of Sciences of the United States of America, 1989
- Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1988
- Interleukin 2 stimulates heart contractility in the presence of exogenous arachidonate or the calcium ionophore A 23187Immunology Letters, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987